MedTrace Logo

Selective Plasmofiltration for Abdominal Septic Shock: a Clinical Ctudy

NCT07121647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2025-08-13

No results posted yet for this study

Summary

Group 1: 34 patients received prolonged hemodiafiltration (CVVHDF) on an emergency basis.

Group 2: 35 patients received early isolated CVVHDF. Group 3: 32 patients received early combined extracorporeal detoxification (ECD) (selective plasma filtration \[SPF\] + CVVHDF).

A comparative analysis of clinical and laboratory parameters was performed.

Conditions

  • Selective Plasma Filtration

Interventions

PROCEDURE

renal replacement therapy.

veno-venous hemodiafiltration for emergency indications (CVVHDF).

PROCEDURE

early isolated CVVHDF.

early isolated CVVHDF.

PROCEDURE

combined extracorporeal blood purification therapy

Patients received early combined extracorporeal blood purification therapy (EBPT) (SPF and CVVHDF).

Sponsors & Collaborators

  • Pirogov Russian National Research Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-15
Primary Completion
2025-02-20
Completion
2025-03-03

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07121647 on ClinicalTrials.gov